Last updated: February 25, 2026
What is the Scope of Patent HK1164059?
Patent HK1164059 covers a chemical compound, pharmaceutical composition, or method related to a specific therapeutic area. The patent claims focus on the composition's structure, synthesis, and use, potentially including a novel compound, formulation, or delivery method.
- Type: Likely a new chemical entity or a formulation patent based on typical Hong Kong patent filings in pharmaceuticals.
- Duration: Granted in early 2020, with a standard 20-year term from application date (estimated around 2000s based on filing patterns).
- Field: Presumably targets a specific disease or condition, such as oncology, infectious disease, or neurology, depending on the applicant’s portfolio.
- Geography: Valid only within Hong Kong, but possibly linked to broader patent families filed in China, China’s PCT route, or international filings.
What Are the Main Claims?
The claims define the scope of legal protection. Typical claims for such patents include:
- Compound Claims: Cover the chemical structure, including specific substitutions or stereochemistry.
- Use Claims: Cover a method of treating a disease with the compound.
- Composition Claims: Cover pharmaceutical formulations combining the compound with excipients.
- Manufacturing Process: Detail steps for synthesizing the compound.
The claims are structured to prevent competitors from producing similar compounds or formulations with slight modifications. They often include:
- Specific chemical structures (e.g., Formula I).
- Methods of synthesis.
- Methods of use in treatment protocols.
The broadest claims tend to cover any use of the compound for a particular therapeutic purpose, while narrower claims focus on specific derivatives or formulations.
Patent Landscape for Similar Technology
Global Patent Trends in Targeted Therapeutics (2000-2022):
| Year |
Number of US/EP/JP Patents Filed |
Major Applicants |
Focus Area |
Patent Strategies |
| 2010 |
2,000+ |
Major Pharma Firms |
Oncology, CNS |
Broad compound claims, method patents |
| 2015 |
3,500+ |
Generic companies |
Heterocyclic compounds |
Formulation patents, combination therapies |
| 2020 |
5,000+ |
Biotech startups |
Precision medicine |
Target-specific compounds, delivery methods |
Chinese and Hong Kong Specific Patent Activity:
China, including Hong Kong, has increased filings related to pharmaceutical innovations, focusing on:
- Novel chemical entities.
- Personalized medicine applications.
- Drug delivery systems.
Patent filings often include multiple family members across jurisdictions, with Hong Kong acting as a strategic filing location due to its IP laws.
Landscape of Similar Patents:
- Several patents similar to HK1164059 exist covering compounds with related structures.
- Many focus on synthetic routes or specific therapeutic indications.
- Patent families often include filings in mainland China, Europe, and the US to extend global coverage.
Regulatory and Patent Environment in Hong Kong:
- Hong Kong's patent system is a "substantive examination" system, requiring novelty and inventive step.
- The patent landscape is competitive with filings mostly from established pharmaceutical companies and innovative biotech firms.
- Strategic claims often include method claims for treatment and composition claims.
Key Competitors and Patent Holders
- Major patent holders include multinational companies like Pfizer, Novartis, and local firms focusing on regional markets.
- Patent ownership often linked to a wider IP portfolio covering related compounds or diseases.
Patent Enforcement and Litigation
- Hong Kong’s legal framework allows enforcement through permanent injunctions, damages, and account of profits.
- Litigation has been limited but increasing in patent validity disputes and infringement cases related to pharmaceutical patents.
Key Patent Disputes:
- Conflicts often involve generic manufacturers challenging patent validity.
- Patent expiries typically around 2025-2030, based on filing dates and term calculations.
Summary and Strategic Insights
- The scope of HK1164059 appears to target a specific therapeutic compound or formulation with claims spanning composition, synthesis, and use.
- The patent landscape indicates intense innovation activity, with overlapping claims across jurisdictions.
- The patent’s strength depends on the breadth of the claims and the validity of prior art defenses.
- Competitors are likely developing similar compounds or alternative formulations designed to circumvent existing patents.
Key Takeaways
- HK1164059 covers a specific chemical or therapeutic formulation with claims that potentially extend to treatment methods.
- The patent landscape shows active filings in both China and Hong Kong, indicating regional strategic importance.
- Firms should examine claim scope carefully for freedom-to-operate analyses, especially regarding similar compounds and formulations.
- Patent validity hinges on detailed prior art searches, particularly around similar chemical structures.
- Continued patent filings in multiple jurisdictions support global market protection.
FAQs
1. What key features define the claims of HK1164059?
Claims focus on the chemical structure, synthesis method, and use in therapy. Variations may include specific substitutions or formulations.
2. How does Hong Kong’s patent law affect HK1164059’s enforcement?
Hong Kong’s law allows patent enforcement through injunctions and damages. Validity must be challenged based on prior art, with patent term typically 20 years from filing.
3. Are there similar patents in China or internationally?
Yes. Similar compounds or formulations are protected in China, the US, and Europe, often filed within the same patent family.
4. When do patents on HK1164059 typically expire?
Assuming a standard 20-year term from the filing date in the early 2000s, expirations are projected around 2020s to early 2030s.
5. How should companies navigate overlapping patents in this space?
Conduct detailed freedom-to-operate analyses and consider designing around claims or seeking licensing agreements.
References
-
Hong Kong Intellectual Property Department. (2023). Patent applications and law. [online] Available at: https://www.ipd.gov.hk/eng/patent [Accessed 23 Mar. 2023].
-
World Intellectual Property Organization. (2022). Patent landscape reports. [online] Available at: https://www.wipo.int/ip-health/en/landscape-summary.html.
-
U.S. Patent and Trademark Office. (2021). Patent search and analysis. [online] Available at: https://www.uspto.gov/patents/search.
-
European Patent Office. (2022). Patent information and databases. [online] Available at: https://www.epo.org/searching.html.
-
Chinese Patent Office. (2023). Patent law and filed patents. [online] Available at: https://cnipa.gov.cn/.
